|1.||Podoloff, Donald A: 2 articles (10/2009 - 10/2004)|
|2.||Yang, David J: 2 articles (10/2009 - 10/2004)|
|3.||Kim, E Edmund: 2 articles (10/2009 - 10/2004)|
|4.||Erwin, William D: 2 articles (10/2009 - 10/2004)|
|5.||Schechter, Naomi R: 2 articles (10/2009 - 10/2004)|
|6.||Cox, James D: 2 articles (10/2009 - 10/2004)|
|7.||Bieńkiewicz, Małgorzata: 1 article (04/2015)|
|8.||Surma, Marian: 1 article (04/2015)|
|9.||Kuśmierek, Jacek: 1 article (04/2015)|
|10.||Płachcińska, Anna: 1 article (04/2015)|
10/01/2004 - "This study assessed the radiation dosimetry of 99mTc-labeled ethylene dicysteine (EC) C225 (EC-C225), a promising radioligand for functional tumor imaging. "
05/01/1999 - "This study aimed to develop a 99mTc-labeled metronidazole (MN) using ethylene-dicysteine (EC) as a chelator and evaluate its potential use to image tumor hypoxia. "
07/17/2013 - "We selected penta-d-Asp as both a targeting motif to hydroxyapatite (HA) and a molecular size modifier, and two penta-d-Asp molecules were conjugated with the two carboxylate residues of ethylene dicysteine (EC) selected as the (99m)Tc chelating moiety to prepare EC-[(d-Asp)5]2. The molecular size, HA binding, and pharmacokinetics of (99m)Tc-EC-[(d-Asp)5]2 in normal mice and model rats bearing osteogenic tumor were compared to those of (99m)Tc-MDP and (99m)Tc-EC with one (d-Asp)5 motif, (99m)Tc-EC-(d-Asp)5. "
09/01/2004 - "To evaluate the clinical usefulness of early cortical phase images in the diagnosis of acute pyelonephritis and to compare the measurements of differential renal function obtained by both 99mTc ethylene dicysteine (99mTc-EC) and 99mTc dimercaptosuccinic acid (99mTc-DMSA). "
09/01/2004 - "99mTc ethylene dicysteine scintigraphy for diagnosing cortical defects in acute pyelonephritis: a comparative study with 99mTc dimercaptosuccinic acid."
|3.||Technetium Tc 99m Dimercaptosuccinic Acid
|5.||Deoxyglucose (2 Deoxy D glucose)